Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?

Item

http://www.wikidata.org/entity/Q57446582

description

im Juni 2013 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 June 2013

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2013

@uk

name

Drospirenone and non-fatal ven ...... y dosage of ethinyl-estradiol?

@en

Drospirenone and non-fatal ven ...... y dosage of ethinyl-estradiol?

@nl

type

Item

label

Drospirenone and non-fatal ven ...... y dosage of ethinyl-estradiol?

@en

Drospirenone and non-fatal ven ...... y dosage of ethinyl-estradiol?

@nl

prefLabel

Drospirenone and non-fatal ven ...... y dosage of ethinyl-estradiol?

@en

Drospirenone and non-fatal ven ...... y dosage of ethinyl-estradiol?

@nl

P1476

Drospirenone and non-fatal ven ...... y dosage of ethinyl-estradiol?

@en

P2093

A G Hartzema

http://www.w3.org/2001/XMLSchema#string

M Etminan

http://www.w3.org/2001/XMLSchema#string

S T Bird

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Problems in dealing with missing data and informative censoring in clinical trials.

Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.

The association between drospirenone and hyperkalemia: a comparative-safety study

Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.

Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.

Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome

P304

1059-1068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.12224

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James M. Brophy

Joseph A Delaney

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23574590

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism